4
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Weight Loss in Underserved Patients — A Cluster-Randomized Trial

      research-article

      Read this article at

      ScienceOpenPublisherPMC
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          BACKGROUND

          Evidence of the effectiveness of treatment for obesity delivered in primary care settings in underserved populations is lacking.

          METHODS

          We conducted a cluster-randomized trial to test the effectiveness of a high-intensity, lifestyle-based program for obesity treatment delivered in primary care clinics in which a high percentage of the patients were from low-income populations. We randomly assigned 18 clinics to provide patients with either an intensive lifestyle intervention, which focused on reduced caloric intake and increased physical activity, or usual care. Patients in the intensive-lifestyle group participated in a high-intensity program delivered by health coaches embedded in the clinics. The program consisted of weekly sessions for the first 6 months, followed by monthly sessions for the remaining 18 months. Patients in the usual-care group received standard care from their primary care team. The primary outcome was the percent change from baseline in body weight at 24 months.

          RESULTS

          All 18 clinics (9 assigned to the intensive program and 9 assigned to usual care) completed 24 months of participation; a median of 40.5 patients were enrolled at each clinic. A total of 803 adults with obesity were enrolled: 452 were assigned to the intensive-lifestyle group, and 351 were assigned to the usual-care group; 67.2% of the patients were Black, and 65.5% had an annual household income of less than $40,000. Of the enrolled patients, 83.4% completed the 24-month trial. The percent weight loss at 24 months was significantly greater in the intensive-lifestyle group (change in body weight, −4.99%; 95% confidence interval [CI], −6.02 to −3.96) than in the usual-care group (−0.48%; 95% CI, −1.57 to 0.61), with a mean between-group difference of −4.51 percentage points (95% CI, −5.93 to −3.10) (P<0.001). There were no significant between-group differences in serious adverse events.

          CONCLUSIONS

          A high-intensity, lifestyle-based treatment program for obesity delivered in an underserved primary care population resulted in clinically significant weight loss at 24 months. (Funded by the Patient-Centered Outcomes Research Institute and others; PROPEL ClinicalTrials.gov number, NCT02561221.)

          Related collections

          Most cited references20

          • Record: found
          • Abstract: found
          • Article: not found

          The Look AHEAD study: a description of the lifestyle intervention and the evidence supporting it.

          The Look AHEAD (Action for Health in Diabetes) study is a multicenter, randomized controlled trial designed to determine whether intentional weight loss reduces cardiovascular morbidity and mortality in overweight individuals with type 2 diabetes. The study began in 2001 and is scheduled to conclude in 2012. A total of 5145 participants have been randomly assigned to a lifestyle intervention or to an enhanced usual care condition (i.e., diabetes support and education). This article describes the lifestyle intervention and the empirical evidence to support it. The two principal intervention goals are to induce a mean loss >or = 7% of initial weight and to increase participants' moderately intense physical activity to > or =175 min/wk. For the first 6 months, participants attend one individual and three group sessions per month and are encouraged to replace two meals and one snack a day with liquid shakes and meal bars. From months 7 to 12, they attend one individual and two group meetings per month and continue to replace one meal per day (which is recommended for the study's duration). Starting at month 7, more intensive behavioral interventions and weight loss medication are available from a toolbox, designed to help participants with limited weight loss. In Years 2 to 4, treatment is provided mainly on an individual basis and includes at least one on-site visit per month and a second contact by telephone, mail, or e-mail. After Year 4, participants are offered monthly individual visits. The intervention is delivered by a multidisciplinary team that includes medical staff who monitor participants at risk of hypoglycemic episodes.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            A two-year randomized trial of obesity treatment in primary care practice.

            Calls for primary care providers (PCPs) to offer obese patients behavioral weight-loss counseling have not been accompanied by adequate guidance on how such care could be delivered. This randomized trial compared weight loss during a 2-year period in response to three lifestyle interventions, all delivered by PCPs in collaboration with auxiliary health professionals (lifestyle coaches) in their practices. We randomly assigned 390 obese adults in six primary care practices to one of three types of intervention: usual care, consisting of quarterly PCP visits that included education about weight management; brief lifestyle counseling, consisting of quarterly PCP visits combined with brief monthly sessions with lifestyle coaches who instructed participants about behavioral weight control; or enhanced brief lifestyle counseling, which provided the same care as described for the previous intervention but included meal replacements or weight-loss medication (orlistat or sibutramine), chosen by the participants in consultation with the PCPs, to potentially increase weight loss. Of the 390 participants, 86% completed the 2-year trial, at which time, the mean (±SE) weight loss with usual care, brief lifestyle counseling, and enhanced brief lifestyle counseling was 1.7±0.7, 2.9±0.7, and 4.6±0.7 kg, respectively. Initial weight decreased at least 5% in 21.5%, 26.0%, and 34.9% of the participants in the three groups, respectively. Enhanced lifestyle counseling was superior to usual care on both these measures of success (P=0.003 and P=0.02, respectively), with no other significant differences among the groups. The benefits of enhanced lifestyle counseling remained even after participants given sibutramine were excluded from the analyses. There were no significant differences between the intervention groups in the occurrence of serious adverse events. Enhanced weight-loss counseling helps about one third of obese patients achieve long-term, clinically meaningful weight loss. (Funded by the National Heart, Lung, and Blood Institute; POWER-UP ClinicalTrials.gov number, NCT00826774.).
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Achieving weight and activity goals among diabetes prevention program lifestyle participants.

              The Diabetes Prevention Program (DPP) showed that intensive lifestyle intervention reduced the risk of diabetes by 58%. This paper examines demographic, psychosocial, and behavioral factors related to achieving weight loss and physical activity goals in the DPP lifestyle participants. Lifestyle participants (n = 1079; mean age = 50.6, BMI = 33.9, 68% female, and 46% from minority groups) had goals of 7% weight loss and 150 min/wk of physical activity. Goal achievement was assessed at the end of the 16-session core curriculum (approximately week 24) and the final intervention visit (mean = 3.2 years) as a function of demographic, psychosocial, and behavioral variables. Forty-nine percent met the weight loss goal and 74% met the activity goal initially, while 37% and 67%, respectively, met these goals long-term. Men and those with lower initial BMI were more likely to meet activity but not weight loss goals. Hispanic, Asian, and Native Americans were more likely to meet the long-term activity goals, and whites were more likely to meet the initial weight loss goal. In multivariate analyses, meeting the long-term weight loss goal and both activity goals increased with age, while psychosocial and depression measures were unrelated to goal achievement. Dietary self-monitoring was positively related to meeting both weight loss and activity goals, and meeting the activity goal was positively related to meeting the weight loss goal. Participants who met initial goals were 1.5 to 3.0 times more likely to meet these goals long-term. Success at meeting the weight loss and activity goals increased with age. Initial success predicted long-term success. Self-monitoring and meeting activity goals were related to achieving and sustaining weight loss.
                Bookmark

                Author and article information

                Contributors
                Journal
                0255562
                5985
                N Engl J Med
                N. Engl. J. Med.
                The New England journal of medicine
                0028-4793
                1533-4406
                10 September 2020
                03 September 2020
                03 March 2021
                : 383
                : 10
                : 909-918
                Affiliations
                Pennington Biomedical Research Center, Baton Rouge
                Pennington Biomedical Research Center, Baton Rouge
                Pennington Biomedical Research Center, Baton Rouge
                Pennington Biomedical Research Center, Baton Rouge
                Department of Medicine and Feist–Weiller Cancer Center, Louisiana State University Health Sciences Center, Shreveport
                Department of Medicine and Feist–Weiller Cancer Center, Louisiana State University Health Sciences Center, Shreveport
                Ochsner Clinic Foundation, Center for Outcomes and Health Services Research, Louisiana; Ochsner Clinical School–University of Queensland School of Medicine, Louisiana
                Pennington Biomedical Research Center, Baton Rouge
                Pennington Biomedical Research Center, Baton Rouge
                Department of Medicine, Division of Endocrinology and Metabolism, Louisiana; Tulane University Health Sciences Center School of Medicine, Southeast Louisiana Veterans Health Care System, Louisiana
                Pennington Biomedical Research Center, Baton Rouge
                Pennington Biomedical Research Center, Baton Rouge
                Department of Medicine, Division of Endocrinology and Metabolism, Louisiana; Tulane University Health Sciences Center School of Medicine, Southeast Louisiana Veterans Health Care System, Louisiana
                Department of Medicine, Section of General Internal Medicine and Geriatrics, Louisiana
                College of Pharmacy, Xavier University of Louisiana, Louisiana
                Department of Cardiovascular Diseases, John Ochsner Heart and Vascular Institute, Louisiana; Ochsner Clinical School–University of Queensland School of Medicine, Louisiana
                College of Pharmacy, Xavier University of Louisiana, Louisiana
                Department of Internal Medicine, Louisiana State University School of Medicine, and Program in Health Policy and Systems Management, Louisiana State University School of Public Health, New Orleans — Louisiana
                Author notes
                Address reprint requests to Dr. Katzmarzyk at the Pennington Biomedical Research Center, 6400 Perkins Rd., Baton Rouge, LA, 70808-4124, or at peter.katzmarzyk@ 123456pbrc.edu .

                We thank the patients and the members of the patient advisory boards, community monitoring board, and the project management committee (Chris Lodge and Ava Zebrick, M.S.), who contributed greatly to the design and conduct of the trial; the trial patients, assessment technicians, and health coaches, without whom this trial would not have been possible; Willie C. White III, M.P.H., and the David Raines Community Health Centers; Gary Wiltz, M.D., and the Teche Action Clinic sites; Michael G. Griffin and Robert Post, M.D., and the Daughters of Charity Services of New Orleans; the Ochsner Health System and Access Health Louisiana clinic sites; the data and safety monitoring board (Robert Ross, Ph.D. [chair], John Lefante, Ph.D., Michael Rolfson, M.D., and Chris Lodge) for overseeing patient safety and the overall conduct of the trial; and David B. Allison, Ph.D., Andrew W. Brown, Ph.D., Stephanie L. Dickinson, M.S., and Lilian Golzarri-Arroyo, M.S., of the Indiana University School of Public Health–Bloomington for reviewing and verifying the statistical methods and results of this project.

                Article
                PMC7493523 PMC7493523 7493523 nihpa1626143
                10.1056/NEJMoa2007448
                7493523
                32877581
                5bae96fd-cbe7-4649-849d-44ac4ea50c5e
                History
                Categories
                Article

                Comments

                Comment on this article